Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.12 ($41,200)
  2. 4 Other acquisition COO & CFO acquired 800 shares (other)
  3. 4 Open-market buy Director bought 900 shares at $4.22 ($3,798)
  4. 4 Open-market buy Director bought 2,000 shares at $4.21 ($8,420)
  5. 4 Open-market buy Chief Executive Officer bought 4,000 shares at $4.21 ($16,840)
  6. 4 Open-market buy Director bought 10,000 shares at $4.28 ($42,800)
  7. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.27 ($42,700)
  8. 4 Open-market buy Director bought 50,000 shares at $4.09 ($204,500)
  9. 4 Open-market buy Director bought 2,000 shares at $4.05 ($8,100)
  10. 4 Open-market buy Chief Executive Officer bought 11,000 shares at $3.90 ($42,900)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy COO & CFO bought 2,250 shares at $4.45 ($10,013)
  17. 4 Open-market buy Chief Executive Officer bought 3,000 shares at $4.08 ($12,240)
  18. 4 Open-market buy Director bought 5,000 shares at $3.98 ($19,900)
  19. 4 Open-market buy Chief Executive Officer bought 3,000 shares at $3.84 ($11,520)
  20. 4 Open-market buy Chief Executive Officer bought 4,112 shares at $3.96 ($16,284)

Page 9 of 24 · 471 filings